The global insulin pump market size was estimated to be US$ 3.77 billion in 2020 and is expected to reach US$ 10.41 billion by 2031 at a CAGR of 9.7%.
Insulin pumps are little automated clinical gadgets that can be connected on to a belt, pocket or stowed away under the garments. The pump is utilized to convey controlled dosages of insulin inside the body at standard stretches, contingent on the customer's basal and bolus rate, to control the ascent in blood glucose levels.
It works through a needle and an adaptable catheter that is utilized to embed insulin straightforwardly into the fatty tissue, which is then taped and gotten set up. Insulin pump treatment, otherwise called continuous subcutaneous insulin infusion (CSII) treatment, is a kind of insulin conveyance framework. CSII has been supported for use in type 1 diabetes patients and a subset of type 2 diabetes patients. Insulin pump innovation is quickly developing, and numerous choices, incorporating those utilized related to persistent glucose checking, are presently accessible.
The expanding fame of these pumps is basically stirred up by the significant advantages of these gadgets contrasted with the traditional multiple daily injections (MDI) treatment. An individual with Type 1 diabetes, for example, requires an everyday implantation of insulin to keep up with glucose levels. On account of MDI, such mixture will either require the patient to visit a clinic or a medical expert to plug the patient at home. These pumps eliminate this burden on the grounds that these gadgets are joined to the patient and are customized to convey the medicine according to the specialist's message.
Moreover, since the cannula of the pump is embedded into the skin, the requirement for incessant infusions is hence shunned out-and-out. Furthermore, as insulin supply can be changed on these pumps as per individual necessities, the likelihood of raised blood glucose levels toward the beginning of the day or the event of hypoglycemic scenes is significantly diminished. The extensive benefits presented by this mechanized gadget over the MDI-based treatment are pushing patients towards embracing these minimal machines and powering their market simultaneously.
Smart advances, for example, simulated intelligence have quickly entered the medical services IT scene and are presently gaining consistent ground in diabetes management. Initiating these patterns are clinical gadget organizations that are effectively creating and presenting man-made intelligence empowered pumps and other mechanized medication conveyance arrangements. For instance, Medtronic's 670G framework has been modified to suspend insulin delivery in instances of real or expected hypoglycemia that is low glucose. Then again, the model has additionally been aligned to naturally change base insulin rates for hyperglycemia.
Other driving factors for the market expansion are as follows:
Rising in general diabetes populace across the world, expanding type 1 diabetes patient number, and they are inclined to extreme entanglement, a few studies across the world shows advantage of Insulin Pump over conventional insulin conveyance, innovation development, nations across the world particularly developed nations broaden their repayment approaches.
By and large, patch pumps are more modest than customary insulin pumps and are more discrete and simpler to utilize. Also, these pumps are more reasonable when contrasted with regular insulin conveyance gadgets, which creates more demand. Patch pumps are connected to the skin utilizing cement layer and because of the trend setting innovation, they require the least checking. These pumps are normally incorporated with blood glucose or a ceaseless glucose observing framework.
North America overwhelmed the market, attributable to accessibility of significant brands of insulin patch pumps. With the quantity of uninsured individuals in the US developing each year, combined with the rising commonness of diabetes, these insulin drug conveyance frameworks are not available to a huge piece of the American public. The circumstance is antagonistic in non-industrial nations. For instance, in India, the expense of these pumps is anyplace between INR 1lakh and INR 4lakh.
Additionally, they are not covered under any health care coverage plot. Non-overhauled wellbeing repayment arrangements in developing economies and significant expenses of insulin gadgets in developed countries will be the two key development restricting factors for this market in coming years.
In Europe, the market will be principally determined by the rising occurrence of diabetes.
Global Insulin Pump Market Value Share Analysis, by Geography (2022)
The report titled “Global Insulin Pump Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Insulin Pump Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Insulin Pump market is segmented as delivery mode, product type, distribution channel, and region. Based on delivery mode, the Insulin Pump market is segmented into Polymerized Rosins of Glycerol Ester (PRGE), Glycerol Esters of Wood Rosin (GEWR), Glycerol Esters of Wood Rosin (GEWR), Penta Ester Gum, others. Based on product type, the Insulin Pump market is segmented into chewing gum, beverages, paints & coatings, adhesives, cosmetics, others. Based on distribution channel, the Insulin Pump market is segmented into chewing gum, beverages, paints & coatings, adhesives, cosmetics, others.
Based on geography, the Global Insulin Pump Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Insulin Pump Market. Further, market share of prominent companies in the Global Insulin Pump Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Insulin Pump companies. The Global Insulin Pump Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Insulin Pump business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Insulin Pump Market.
The key players of the Global Insulin Pump Market are Roche Diagnostics, Valeritus, Medtronic Plc, Cellnovo Ltd, CeQur, Insulet Corporation, and others.
Global Insulin Pump Market Key Segments:
Based on delivery mode
Based on product type
Based on distribution channel
By Region
The global Insulin Pump market was worth US$ 3.77 billion in 2020.
The global Insulin Pump market is expected to register a CAGR of 9.7% between 2022 and 2032.
North America is the principal contributor to the global Insulin Pump market.
Roche Diagnostics, Valeritus, Medtronic Plc, Cellnovo Ltd, CeQur, Insulet Corporation are few prominent players active in the market.
Rising in general diabetes populace across the world, expanding type 1 diabetes patient number, and they are inclined to extreme entanglement, a few studies across the world shows advantage of Insulin Pump over conventional insulin conveyance, innovation development, nations across the world particularly developed nations broaden their repayment approaches.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved